ascopubs.org

A single-center, prospective, randomized controlled trial of tislelizumab combined with platinum-containing chemotherapy as first-line treatment for HIV-positive patients with ...

First-line camrelizumab plus chemotherapy in patients with advanced non-squamous non-small cell lung cancer: A nationwide, retrospective real-world study. This is an ASCO Meeting Abstract from the ...
The University of Alabama at Birmingham

Pilot study finds promising results for treatment of long COVID with brain fog

Results from a small randomized controlled clinical trial show promising findings about a new type of therapy for patients ...
ascopubs.org

A prospective, randomized, cross-over trial to assess patient preference for goserelin microsphere versus goserelin implant in prostate cancer: Interim results of the GOMIMP study.

Comparative real-world survival and prescription patterns of darolutamide versus apalutamide in non-metastatic hormone-resistant prostate cancer. This is an ASCO Meeting Abstract from the 2026 ASCO ...
The American Journal of Managed Care

Assay Finds Patients Who Will Benefit From Adjuvant Chemotherapy in Early-Stage NSCLC

Biomarker testing identifies high-risk early-stage NSCLC patients for adjuvant chemotherapy, reducing recurrence risk by 78%. The AIM-HIGH study shows a 96% disease-free survival rate at 24 months ...
TCTMD

A Prospective, Randomized Clinical Trial of Hemodynamic Support with a Newly Developed pVAD Versus IABP in Patients Undergoing High-Risk Percutaneous Coronary Intervention

Immediate Instantaneous Wave-Free Ratio Guided Versus Deferred Cardiac Magnetic Resonance Imaging Guided Revascularization of Non-Culprit Lesions in Patients with Acute ST-Elevation Myocardial ...

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

PuraPly® AM is a patent-protected product that is differentiated among all skin substitutes by combining a native, cross-linked collagen matrix with polyhexamethylene biguanide (PHMB) antimicrobial to ...

REVA Medical, LLC: REVA Medical Announces Positive MOTIV BTK Trial Results Showing Superiority in Patients with Critical Limb-Threatening Ischemia

MOTIV BTK randomized trial met primary efficacy endpoint, with early and sustained clinical benefit in a complex patient populationSAN DIEGO, April 21, 2026 /PRNewswire/ -- REVA Medical, LLC ...
TCTMD

Prospective Randomized Trial Evaluating Clinical Outcomes of Angiography-Based Fractional Flow Reserve Guidance Versus Wire-Based Fractional Flow Reserve Guidance: The ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
MedPage Today

Randomized Comparison of MRI vs Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial

Richard T. Bryan, PhD, Wenyu Liu, PhD, Sarah J. Pirrie, MSc, Rashid Amir, FRCR, Jean Gallagher, Ana I. Hughes, MSc, Kieran P. Jefferson, FRCS, Allen Knight, MBA ...